Cerebrospinal fluid as a medium of liquid biopsy in the management of patients with non-small-cell lung cancer having central nervous system metastasis by Chi-Lu Chiang, Hsu-Ching Huang, Yung-Hung Luo, Chao-Hua Chiu

Get full text

Pathological complete response after afatinib treatment of stage IV oligometastatic adenocarcinoma of the lung: the role of pulmonary surgery by Ping-Chung Tsai, Yi-Chen Yeh, Chien-Sheng Huang, Chao-Hua Chiu

Get full text

Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report by Chia-I Shen, MD, Yi-Chen Yeh, MD, Chao-Hua Chiu, MD

Get full text

Dynamic Assessment of Tissue and Plasma <i>EGFR</i>-Activating and T790M Mutations with Droplet Digital PCR Assays for Monitoring Response and Resistance in Non-Small Cell Lung Can... by Hsiang-Ling Ho, Fang-Yu Wang, Chi-Lu Chiang, Chun-Ming Tsai, Chao-Hua Chiu, Teh-Ying Chou

Get full text

Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer by Chia-I Shen, Chi-Lu Chiang, Tsu-Hui Shiao, Yung-Hung Luo, Heng-Sheng Chao, Hsu-Ching Huang, Chao-Hua Chiu

Get full text

Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer by Chia-I Shen, Heng-Sheng Chao, Tsu-Hui Shiao, Chi-Lu Chiang, Hsu-Ching Huang, Yung-Hung Luo, Chao-Hua Chiu, Yuh-Min Chen

Get full text

Reduced FEV1 as Prognostic Factors in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors by Yi-Luen Shen, Yi-Luen Shen, Chia-I Shen, Chia-I Shen, Chia-I Shen, Chi-Lu Chiang, Chi-Lu Chiang, Chi-Lu Chiang, Hsu-Ching Huang, Hsu-Ching Huang, Kun-Ta Chou, Kun-Ta Chou, Kun-Ta Chou, Chao-Hua Chiu, Chao-Hua Chiu, Yuh-Min Chen, Yuh-Min Chen, Yung-Hung Luo, Yung-Hung Luo

Get full text

Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell‐free DNA from non‐small‐cell lung cancer patients with leptomeningeal metastases by Chi‐Lu Chiang, Hsiang‐Ling Ho, Yi‐Chen Yeh, Cheng‐Chia Lee, Hsu‐Ching Huang, Chia‐I Shen, Yung‐Hung Luo, Yuh‐Min Chen, Chao‐Hua Chiu, Teh‐Ying Chou

Get full text

Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer. by Hsiang-Ling Ho, Yuqiu Jiang, Chi-Lu Chiang, Sylwia Karwowska, Ranga Yerram, Keerti Sharma, Sidney Scudder, Chao-Hua Chiu, Chun-Ming Tsai, John F Palma, Abha Sharma, Teh-Ying Chou

Get full text

Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer. by Hsiu-Ying Hung, Yen-Han Tseng, Heng-Sheng Chao, Chao-Hua Chiu, Wen-Hu Hsu, Han-Shui Hsu, Yu-Chung Wu, Teh-Ying Chou, Chun-Ku Chen, Keng-Li Lan, Yi-Wei Chen, Yuan-Hung Wu, Yuh-Min Chen

Get full text

Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids by Yuan‐Hung Wu, Heng‐sheng Chao, Chi‐Lu Chiang, Yung‐Hung Luo, Chao‐Hua Chiu, Sang‐Hue Yen, Chun‐Yu Liu, Jeng‐Fong Chiou, Thierry Burnouf, Yin‐Ju Chen, Peng‐Yuan Wang, Tsu‐Yi Chao, Shih‐Ming Hsu, Long‐Sheng Lu

Get full text

Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan by Yuh-Min Chen, James Chih-Hsin Yang, Wu-Chou Su, Inn-Wen Chong, Te-Chun Hsia, Meng-Chih Lin, Gee-Chen Chang, Chao-Hua Chiu, Chao-Chi Ho, Shang-Yin Wu, Jen-Yu Hung, Chin-Chou Wang, Tsung-Ying Yang, Chong-Jen Yu

Get full text

Old age and EGFR mutation status in inoperable early‐stage non‐small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 pat... by Yuan‐Hung Wu, Yu‐Mei Kang, Yu‐Wen Hu, Keng‐Li Lan, Sang‐Hue Yen, Tzu‐Yu Lai, Tien‐Li Lan, Yuh‐Min Chen, Chao‐Hua Chiu, Yung‐Hung Luo, Heng‐sheng Chao, Chi‐Lu Chiang, Tsu‐Hui Shiao, Chao‐Neng Yang, Wen‐Hu Hsu, Yu‐Chung Wu, Han‐Shui Hsu, Jung‐Jyh Hung, Chien‐Sheng Huang, Po‐Kuei Hsu, Yi‐Wei Chen

Get full text

Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC by Alexander Drilon, MD, Chao-Hua Chiu, MD, Yun Fan, MD, Byoung Chul Cho, MD, PhD, Shun Lu, MD, PhD, Myung-Ju Ahn, MD, PhD, Matthew G. Krebs, MD, PhD, Stephen V. Liu, MD, Thomas John, MD, Gregory A. Otterson, MD, Daniel S.W. Tan, MD, Tejas Patil, MD, Rafal Dziadziuszko, MD, PhD, Erminia Massarelli, MD, PhD, Takashi Seto, MD, Robert C. Doebele, MD, PhD, Bethany Pitcher, MSc, Nino Kurtsikidze, MD, Sebastian Heinzmann, PhD, Salvatore Siena, MD

Get full text

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC by Qing Zhou, MD, PhD, Ross A. Soo, MBBS, PhD, Gee-Chen Chang, MD, PhD, Chao-Hua Chiu, MD, Hidetoshi Hayashi, MD, PhD, Sang-We Kim, MD, PhD, Shunsuke Teraoka, MD, Yasushi Goto, MD, PhD, Jianying Zhou, MD, Victor Ho-Fun Lee, MD, Dong-Wan Kim, MD, PhD, Baohui Han, MD, PhD, James Chung Man Ho, MD, FRCP, Chia-Chi Lin, MD, PhD, Shun Lu, MD, Anna Polli, BS, Anna Maria Calella, PhD, Jean-François Martini, PhD, Chew Hooi Wong, PhD, Tony Mok, MD, Hye Ryun Kim, MD, PhD, Yi-Long Wu, MD

Get full text